Related Experiment Videos

Mass spectrometric sequencing of site-specific carcinogen-modified oligodeoxyribonucleotides containing bulky

J Ni1, T Liu, A Kolbanovskiy

  • 1American Health Foundation, Valhalla, New York 10595, USA.

Analytical Biochemistry
|December 29, 1998
PubMed

Insights

Researchers used mass spectrometry to identify where the carcinogen benzo[a]pyrene binds to DNA. This method rapidly sequences carcinogen-DNA adducts, confirming binding sites for biological studies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Background:

  • Site-specific carcinogen-modified oligonucleotides are crucial for studying DNA structure-function relationships.
  • Characterizing carcinogen-DNA adducts requires confirming the exact sites of carcinogen binding post-synthesis.

Purpose of the Study:

  • To demonstrate a rapid and convenient method for sequencing carcinogen-DNA adducts.
  • To accurately establish the binding site of benzo[a]pyrene diol epoxide (BPDE) on an oligonucleotide.

Main Methods:

  • Utilizing negative ion mode electrospray tandem mass spectrometry.
  • Employing collision-induced dissociation (CID) for fragment analysis.
  • Comparing experimental CID fragment mass/charge ratios with calculated values.

Main Results:

  • Successfully sequenced products from the reaction of anti-BPDE with the oligonucleotide d(CATGCGGCCTAC).
  • Accurately identified the specific deoxyguanosine (dG) residue modified by anti-BPDE.
  • Demonstrated the utility of mass spectrometry for characterizing carcinogen-DNA adducts.

Conclusions:

  • Negative ion mode electrospray tandem mass spectrometry coupled with CID is a powerful tool for analyzing carcinogen-DNA adducts.
  • This technique enables precise determination of carcinogen binding sites on oligonucleotides.
  • The findings facilitate further research into the structure-function relationships of carcinogen-modified DNA.

Related Concept Videos